The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating the efficacy of commercial teclistamab in relapsed refractory multiple myeloma patients with prior exposure to anti-BCMA therapies.
Ross Firestone
No Relationships to Disclose
Tala Shekarkhand
No Relationships to Disclose
Dhwani Patel
No Relationships to Disclose
Carlyn Rose Co Tan
Employment - Janssen Research & Development (I)
Stock and Other Ownership Interests - ImmunityBio (I); Johnson & Johnson/Janssen (I); Moderna Therapeutics (I); Nektar (I); Pfizer (I)
Consulting or Advisory Role - Janssen medical Affairs
Research Funding - Janssen; Takeda
Malin Hultcrantz
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Curio Science; GlaxoSmithKline; Intellisphere; Projects in Knowledge
Research Funding - Amgen (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst)
Alexander M. Lesokhin
Honoraria - ITeos Therapeutics; Janssen; Legend Biotech; Pfizer; Sanofi; Trillium Therapeutics
Consulting or Advisory Role - Pfizer; Trillium Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst); Trillium Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Serametrix, Inc
Sham Mailankody
Honoraria - OncLive/MJH Life Sciences; Physicans' Education Resource; Plexus
Consulting or Advisory Role - Janssen Oncology; Legend Biotech; Optum; Optum
Research Funding - Alimera Sciences (Inst); Bristol-Myers Squibb (Inst); Fate Therapeutics; Fate Therapeutics; Janssen Oncology (Inst); Juno Therapeutics (Inst); Takeda (Inst)
Hani Hassoun
Consulting or Advisory Role - Novartis
Research Funding - Janssen; Takeda
Urvi A Shah
Honoraria - Association of Community Cancer Centers (ACCC); MashupMD; MJH Life Sciences; OncLive/MJH Life Sciences; Phillips Gilmore Oncology; RedMedEd
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Janssen Oncology; Sanofi
Research Funding - Celgene/Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Plantable (Inst)
Neha Korde
Honoraria - Cancer Network; Clinical Care Options; Intellisphere; Onc Live; PER; Remedy Health
Consulting or Advisory Role - Janssen Oncology
Research Funding - Abbvie; Amgen; Epizyme; Janssen
Kylee Maclachlan
No Relationships to Disclose
Heather Jolie Landau
Consulting or Advisory Role - Amgen; Caelum Biosciences; Celgene; Clinical Care Options; HCA Healthcare; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Spectrum Pharmaceuticals; Takeda
Research Funding - Takeda
Michael Scordo
Honoraria - i3 CME; Medscape
Consulting or Advisory Role - Angiocrine Bioscience; Kite/Gilead; McKinsey & Company; Omeros
Research Funding - Amgen (Inst); Angiocrine Bioscience; Omeros (Inst)
Travel, Accommodations, Expenses - Kite/Gilead
David J. Chung
Research Funding - Genentech
Gunjan L. Shah
Consulting or Advisory Role - Arcellx
Research Funding - Amgen (Inst); BeyondSpring Pharmaceuticals (Inst); Bristol-Myers Squibb/Celgene (Inst); Janssen (Inst)
Oscar Boutros Lahoud
Consulting or Advisory Role - MorphoSys
Travel, Accommodations, Expenses - MorphoSys
Sergio Giralt
Honoraria - Amgen; Celgene; Jazz Pharmaceuticals; Sanofi; Takeda
Consulting or Advisory Role - Actinuum; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Jazz Pharmaceuticals; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - Actinuum; Amgen; Celgene (Inst); Celgene (Inst); Johnson & Johnson; Miltenyi Biotec (Inst); Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Sanofi
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Celgene; Genentech; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Merck; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Pharmacyclics; Sanofi; Seagen; Skyline Diagnostics